Authors:
SCHUURING E
VANDAMME H
SCHUURINGSCHOLTES E
VERHOEVEN E
MICHALIDES R
GEELEN E
DEBOER C
BROK H
VANBUUREN V
KLUIN P
Citation: E. Schuuring et al., CHARACTERIZATION OF THE EMS1 GENE AND ITS PRODUCT, HUMAN CORTACTIN, Cell adhesion and communication (Softback), 6(2-3), 1998, pp. 185-209
Citation: Jw. Vaandrager et al., THE T(11-14) (Q13-Q32) IN MULTIPLE-MYELOMA CELL-LINE KMS12 HAS ITS 11Q13 BREAKPOINT 330 KB CENTROMERIC FROM THE CYCLIN D1 GENE, Blood, 89(1), 1997, pp. 349-350
Authors:
DRILLENBURG P
VANDERVOORT R
KOOPMAN G
DRAGOSICS B
VANKRIEKEN JHJM
KLUIN P
MEENAN J
LAZAROVITS AI
RADASZKIEWICZ T
PALS ST
Citation: P. Drillenburg et al., PREFERENTIAL EXPRESSION OF THE MUCOSAL HOMING RECEPTOR INTEGRIN ALPHA(4)BETA(7) IN GASTROINTESTINAL NON-HODGKINS-LYMPHOMAS, The American journal of pathology, 150(3), 1997, pp. 919-927
Authors:
BRUMSEN C
LANDMAN JO
KLUIN P
HAMDY NAT
PAPAPOULOS SE
Citation: C. Brumsen et al., SHOULD WE SCREEN FOR MASTOCYTOSIS IN PATIENTS WITH VERTEBRAL FRACTURES, Journal of bone and mineral research, 11, 1996, pp. 644-644
Authors:
GEELEN FAMJ
BELJAARDS RC
VANDERPUTTE SCJ
KLUIN P
WILLEMZE R
Citation: Famj. Geelen et al., DIFFERENCES IN THE EXPRESSION OF BCL-2 PROTEIN AND ADHESION MOLECULESBETWEEN PROGNOSTICALLY DIFFERENT GROUPS OF PRIMARY CUTANEOUS LARGE B-CELL LYMPHOMAS, Journal of investigative dermatology, 107(3), 1996, pp. 315-315
Authors:
HIDDEMANN W
BRITTINGER G
TIEMANN M
PARWARESCH R
STEIN H
LISTER AT
NORTON A
PITTALUGA S
DEWOLFPEETERS C
VANHOOF A
COIFFIER B
BERGER F
KLUINNELEMANNS H
VANKRIEKEN H
KLUIN P
CAVALLI F
ROGGERO E
PEDRINIS E
MONTSERRAT E
PIRIS MA
UNTERHALT M
Citation: W. Hiddemann et al., CLINICAL CHARACTERISTICS AND RESPONSE TO CHEMOTHERAPY OF MANTLE CELL LYMPHOMAS - RESULTS OF A EUROPEAN SURVEY, Blood, 88(10), 1996, pp. 2683-2683
Authors:
DEBOER C
LOYSON S
KLUIN P
SCHUURING E
VANKRIEKEN JH
Citation: C. Deboer et al., MULTIPLE BREAKPOINTS IN THE BCL1 LOCUS IN B-CELL LYMPHOMA - REARRANGEMENT AND EXPRESSION OF THE CYCLIN-D1 GENE, Blood, 82(10), 1993, pp. 10000133-10000133